Unknown

Dataset Information

0

Inhibition of macrophage histone demethylase JMJD3 protects against abdominal aortic aneurysms.


ABSTRACT: Abdominal aortic aneurysms (AAAs) are a life-threatening disease for which there is a lack of effective therapy preventing aortic rupture. During AAA formation, pathological vascular remodeling is driven by macrophage infiltration, and the mechanisms regulating macrophage-mediated inflammation remain undefined. Recent evidence suggests that an epigenetic enzyme, JMJD3, plays a critical role in establishing macrophage phenotype. Using single-cell RNA sequencing of human AAA tissues, we identified increased JMJD3 in aortic monocyte/macrophages resulting in up-regulation of an inflammatory immune response. Mechanistically, we report that interferon-β regulates Jmjd3 expression via JAK/STAT and that JMJD3 induces NF-κB-mediated inflammatory gene transcription in infiltrating aortic macrophages. In vivo targeted inhibition of JMJD3 with myeloid-specific genetic depletion (JMJD3f/fLyz2Cre+) or pharmacological inhibition in the elastase or angiotensin II-induced AAA model preserved the repressive H3K27me3 on inflammatory gene promoters and markedly reduced AAA expansion and attenuated macrophage-mediated inflammation. Together, our findings suggest that cell-specific pharmacologic therapy targeting JMJD3 may be an effective intervention for AAA expansion.

SUBMITTER: Davis FM 

PROVIDER: S-EPMC8008365 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5068228 | biostudies-literature
| S-EPMC7720778 | biostudies-literature
| S-EPMC9279410 | biostudies-literature
2021-02-13 | GSE166676 | GEO
| S-EPMC3057574 | biostudies-literature
| S-EPMC6314955 | biostudies-literature
| S-EPMC9908993 | biostudies-literature
| S-EPMC8021107 | biostudies-literature
| S-EPMC7018578 | biostudies-literature
2021-01-26 | GSE165470 | GEO